Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03583944
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Inc. 200
Testing effectiveness (Phase 2)UnknownNCT01249521
What this trial is testing

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Austin Health 40
Early research (Phase 1)Looking for participantsNCT07130916
What this trial is testing

Aumolertinib in European Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT05403333
What this trial is testing

Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsLocally Advanced or Metastatic Breast Cancer
Fudan University 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT02546232
What this trial is testing

Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

Who this might be right for
Breast Cancer
Oslo University Hospital 196
Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4
Testing effectiveness (Phase 2)Study completedNCT01681212
What this trial is testing

Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 21
Testing effectiveness (Phase 2)Ended earlyNCT04460430
What this trial is testing

Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 12
Large-scale testing (Phase 3)Looking for participantsNCT05860465
What this trial is testing

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd 254
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Early research (Phase 1)Study completedNCT02239900
What this trial is testing

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Who this might be right for
Liver CancerLung Cancer
M.D. Anderson Cancer Center 143
Testing effectiveness (Phase 2)Study completedNCT02360501
What this trial is testing

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)Study completedNCT04995419
What this trial is testing

Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy

Who this might be right for
Metastatic Urothelial Cancer
Astellas Pharma China, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Not applicableStudy completedNCT05396807
What this trial is testing

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Who this might be right for
Metastatic Colon Cancer
University of Rome Tor Vergata 106
Very early researchActive Not RecruitingNCT05488366
What this trial is testing

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
University of California, Irvine 9
Early research (Phase 1)Study completedNCT02138929
What this trial is testing

LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 25
Large-scale testing (Phase 3)Looking for participantsNCT06658353
What this trial is testing

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Jiangsu vcare pharmaceutical technology co., LTD 54
Next Page